CVRx Inc (NAS:CVRX)
$ 8.62 0.31 (3.73%) Market Cap: 186.15 Mil Enterprise Value: 129.94 Mil PE Ratio: 0 PB Ratio: 2.81 GF Score: 34/100

CVRx Inc at JPMorgan Healthcare Conference Transcript

Jan 10, 2024 / 11:45PM GMT
Release Date Price: $28.45 (+1.17%)
Rohan Patel JPMorgan Chase;Co.;Analyst

&-

Hi, everyone. My name is Rohan Patel. I work on the medical devices and research team at JPMorgan. I just want to say, it's my pleasure to introduce our CEO, Nadim Yared of CVRx to provide his opening remarks.

Nadim Yared
CVRx Inc - President, Chief Executive Officer, Director

Thank you, Rohan and thanks, JPMorgan, for the opportunity here to speak. It's been a couple of years and here in a row, but this is the first time we're sitting at the adult stable and the speaker room. We said, a bit impressive, thank you, Rohan.

Forward looking statements -- and we're here to talk about CVRx. It's a great company. We'll be talking about the product about the technology and but we're only limited to 20 minutes of slides to go as fast as possible, slight shrinkage even further. So as we get an answer more questions toward the end. So be ready with your questions.

Our company CVRx developed the first FDA approved neuro modulation device that is addressing a cardiovascular disease. We

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot